Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis

Xiao-Ni Chai, Bing-Qian Zhou, Ni Ning, Ting Pan, Fan Xu, Si-Han He, Ni-Ni Chen, Mei Sun, Xiao-Ni Chai, Bing-Qian Zhou, Ni Ning, Ting Pan, Fan Xu, Si-Han He, Ni-Ni Chen, Mei Sun

Abstract

Introduction: This systematic review and meta-analysis evaluates the overall effects of lifestyle interventions upon hepatic fat content and metabolism-related indicators among adults with metabolic associated fatty liver disease.

Methods: It was registered under PROSPERO (CRD42021251527). We searched PubMed, EMBASE, MEDLINE, Cochrane, CINAHL, Scopus, CNKI, Wan-fang, VIP, and CBM from the inception of each database to May 2021 for RCT studies of lifestyle interventions on hepatic fat content and metabolism-related indicators. We used Review Manager 5.3 for meta-analysis and used text and detailed tabular summaries when heterogeneity existed.

Results: Thirty-four RCT studies with 2652 participants were included. All participants were obesity, 8% of whom also had diabetes, and none was lean or normal weight. Through subgroup analysis, we found low carbohydrate diet, aerobic training and resistance training significantly improved the level of HFC, TG, HDL, HbA1c, and HOMA-IR. Moreover, low carbohydrate diet is more effective in improving HFC than low fat diet and resistance training is better than aerobic training in reduction in HFC and TG (SMD, -0.25, 95% CI, -0.45 to -0.06; SMD, 0.24, 95% CI, 0.03 to 0.44, respectively).

Discussion: Overall, this is the first review that systematically synthesizes studies focused on the effects of various lifestyle on adults with MAFLD. The data generated in this systematic review were more applicable to obesity MAFLD rather than lean or normal weight MAFLD.

Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier (CRD42021251527).

Keywords: MAFLD; diet; exercise; lifestyle; meta-analysis; systematic review.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2023 Chai, Zhou, Ning, Pan, Xu, He, Chen and Sun.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
Figure 2
Figure 2
Methodological quality of included studies.
Figure 3
Figure 3
Effect of aerobic training vs. control group on MAFLD.
Figure 4
Figure 4
Effect of resistance training vs. control group on MAFLD.
Figure 5
Figure 5
Effect of aerobic training vs. resistance training on MAFLD.

References

    1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases. Hepatology (2018) 67(1):328–57. doi: 10.1002/hep.29367
    1. Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. . A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol (2020) 73(1):202–9. doi: 10.1016/j.jhep.2020.03.039
    1. Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. . The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int (2020) 14(6):889–919. doi: 10.1007/s12072-020-10094-2
    1. Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism (2016) 65(8):1017–25. doi: 10.1016/j.metabol.2016.01.012
    1. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. . Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol (2018) 15(1):11–20. doi: 10.1038/nrgastro.2017.109
    1. Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. . Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology (2019) 69(6):2672–82. doi: 10.1002/hep.30251
    1. Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: Latest trends. Curr Obes Rep (2018) 7(4):276–88. doi: 10.1007/s13679-018-0317-8
    1. EASL-EASD-EASO . EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia (2016) 59(6):1121–40. doi: 10.1007/s00125-016-3902-y
    1. Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology (2012) 55(6):1738–45. doi: 10.1002/hep.25548
    1. Zelber-Sagi S, Buch A, Yeshua H, Vaisman N, Webb M, Harari G, et al. . Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol (2014) 20(15):4382–92. doi: 10.3748/wjg.v20.i15.4382
    1. Razavi Zade M, Telkabadi MH, Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int (2016) 36(4):563–71. doi: 10.1111/liv.12990
    1. Zhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, et al. . Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: A randomized clinical trial. JAMA Intern Med (2016) 176(8):1074–82. doi: 10.1001/jamainternmed.2016.3202
    1. Katsagoni CN, Papatheodoridis GV, Ioannidou P, Deutsch M, Alexopoulou A, Papadopoulos N, et al. . Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. Br J Nutr (2018) 120(2):164–75. doi: 10.1017/S000711451800137X
    1. Properzi C, O’Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, et al. . Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: A randomized controlled trial. Hepatology (2018) 68(5):1741–54. doi: 10.1002/hep.30076
    1. Dorosti M, Jafary Heidarloo A, Bakhshimoghaddam F, Alizadeh M. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. Br J Nutr (2020) 123(3):328–36. doi: 10.1017/S0007114519002769
    1. Kaliora AC, Kokkinos A, Diolintzi A, Stoupaki M, Gioxari A, Kanellos PT, et al. . The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention. Food Funct (2016) 7(11):4533–44. doi: 10.1039/c6fo01040g
    1. Cai H, Qin YL, Shi ZY, Chen JH, Zeng MJ, Zhou W, et al. . Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterol (2019) 19(1):219. doi: 10.1186/s12876-019-1132-8
    1. Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, Elnegamy TE, Soliman GS, et al. . Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial. Med (Baltimore) (2020) 99(10):e19471. doi: 10.1097/MD.0000000000019471
    1. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol (2012) 56(1):255–66. doi: 10.1016/j.jhep.2011.06.010
    1. Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: A meta-analysis and meta-regression. Clin Gastroenterol Hepatol (2016) 14(10):1398–411. doi: 10.1016/j.cgh.2016.04.036
    1. Medrano M, Cadenas-Sanchez C, Alvarez-Bueno C, Cavero-Redondo I, Ruiz JR, Ortega FB, et al. . Evidence-based exercise recommendations to reduce hepatic fat content in youth- a systematic review and meta-analysis. Prog Cardiovasc Dis (2018) 61(2):222–31. doi: 10.1016/j.pcad.2018.01.013
    1. Utz-Melere M, Targa-Ferreira C, Lessa-Horta B, Epifanio M, Mouzaki M, Mattos AA. Non-alcoholic fatty liver disease in children and adolescents: Lifestyle change - a systematic review and meta-analysis. Ann Hepatol (2018) 17(3):345–54. doi: 10.5604/01.3001.0011.7380
    1. Mann JP, Tang GY, Nobili V, Armstrong MJ. Evaluations of lifestyle, dietary, and pharmacologic treatments for pediatric nonalcoholic fatty liver disease: A systematic review. Clin Gastroenterol Hepatol (2019) 17(8):1457–1476 e1457. doi: 10.1016/j.cgh.2018.05.023
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 339:b2700. doi: 10.1136/bmj.b2700
    1. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. . Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (2010) 51(1):121–9. doi: 10.1002/hep.23276
    1. Arefhosseini SR, Ebrahimi-Mameghani M, Farsad Naeimi A, Khoshbaten M, Rashid J. Lifestyle modification through dietary intervention: Health promotion of patients with non-alcoholic fatty liver disease. Health Promot Perspect (2011) 1(2):147–54. doi: 10.5681/hpp.2011.016
    1. Al-Jiffri O, Al-Sharif FM, Abd El-Kader SM, Ashmawy EM. Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. Afr Health Sci (2013) 13(3):667–72. doi: 10.4314/ahs.v13i3.21
    1. Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, et al. . Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial). Hepatology (2013) 58(4):1287–95. doi: 10.1002/hep.26393
    1. Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, et al. . Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci (Lond) (2015) 129(12):1097–105. doi: 10.1042/CS20150308
    1. Elsisia HF, Aneisb YM. High-intensity circuit weight training versus aerobic training in patients with nonalcoholic fatty liver disease. Bull Faculty Phys Ther (2016) 20(2):181–92. doi: 10.4103/1110-6611.174717
    1. Abd El-Kader SM, Al-Shreef FM, Al-Jiffri OH. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis. Afr Health Sci (2016) 16(1):242–9. doi: 10.4314/ahs.v16i1.32
    1. Rezende RE, Duarte SM, Stefano JT, Roschel H, Gualano B, de Sa Pinto AL, et al. . Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. Menopause (2016) 23(8):876–83. doi: 10.1097/GME.0000000000000647
    1. Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, et al. . Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol (2017) 15(1):96–102.e103. doi: 10.1016/j.cgh.2016.07.031
    1. Oh S, So R, Shida T, Matsuo T, Kim B, Akiyama K, et al. . High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease. Sci Rep (2017) 7:43029. doi: 10.1038/srep43029
    1. Jia GY, Han T, Gao L, Wang L, Wang SC, Yang L, et al. . A randomized controlled study of aerobic and resistance exercise to improve nonalcoholic fatty liver disease. Chin J Liver Dis (2018) 26(01):34–41. doi: 10.3760/cma.j.issn.1007-3418.2018.01.009
    1. Eslami O, Shidfar F, Maleki Z, Jazayeri S, Hosseini AF, Agah S, et al. . Effect of soy milk on metabolic status of patients with nonalcoholic fatty liver disease: A randomized clinical trial. J Am Coll Nutr (2019) 38(1):51–8. doi: 10.1080/07315724.2018.1479990
    1. Rezaei S, Akhlaghi M, Sasani MR, Barati Boldaji R. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Nutrition (2019) 57:154–61. doi: 10.1016/j.nut.2018.02.021
    1. Maleki Z, Jazayeri S, Eslami O, Shidfar F, Hosseini AF, Agah S, et al. . Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Complement Ther Med (2019) 44:44–50. doi: 10.1016/j.ctim.2019.02.020
    1. Gheflati A, Adelnia E, Nadjarzadeh A. The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. Phytother Res (2019) 33(5):1501–9. doi: 10.1002/ptr.6342
    1. Deibert P, Lazaro A, Schaffner D, Berg A, Koenig D, Kreisel W, et al. . Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World J Gastroenterol (2019) 25(9):1116–31. doi: 10.3748/wjg.v25.i9.1116
    1. Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, Soliman GS. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. Med (Baltimore) (2019) 98(12):e14918. doi: 10.1097/MD.0000000000014918
    1. Lim SL, Johal J, Ong KW, Han CY, Chan YH, Lee YM, et al. . Lifestyle intervention enabled by mobile technology on weight loss in patients with nonalcoholic fatty liver disease: Randomized controlled trial. JMIR Mhealth Uhealth (2020) 8(4):e14802. doi: 10.2196/14802
    1. Liu YY, Liu YP, Liu YR, Sun P. A prospective study on the implementation of aerobic exercise intervention in patients with metabolism-related fatty liver disease. J Clin Hepatol (2020) 36(11):2467–72. doi: 10.3969/j.issn.1001-5256.2020.11.014
    1. Çevik Saldiran T, Mutluay FK, Yağci İ., Yilmaz Y. Impact of aerobic training with and without whole-body vibration training on metabolic features and quality of life in non-alcoholic fatty liver disease patients. Ann Endocrinol (Paris) (2020) 81(5):493–9. doi: 10.1016/j.ando.2020.05.003
    1. Ristic-Medic D, Kovacic M, Takic M, Arsic A, Petrovic S, Paunovic M, et al. . Calorie-restricted Mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease. Nutrients (2020) 13(1):15. doi: 10.3390/nu13010015
    1. Holmer M, Lindqvist C, Petersson S, Moshtaghi-Svensson J, Tillander V, Brismar TB, et al. . Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. JHEP Rep (2021) 3(3):100256. doi: 10.1016/j.jhepr.2021.100256
    1. Garousi N, Tamizifar B, Pourmasoumi M, Feizi A, Askari G, Clark CCT, et al. . Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial. Arch Physiol Biochem (2021) 9:1–9. doi: 10.1080/13813455.2021.1890128
    1. Marin-Alejandre BA, Cantero I, Perez-Diaz-Del-Campo N, Monreal JI, Elorz M, Herrero JI, et al. . Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial. Liver Int (2021) 41(7):1532–44. doi: 10.1111/liv.14818
    1. Hansen CD, Gram-Kampmann EM, Hansen JK, Hugger MB, Madsen BS, Jensen JM, et al. . Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease. Ann Internal Med (2023) 176(1):10–22. doi: 10.7326/P22-0022
    1. Ahn J, Jun DW, Lee HY, Moon JH. Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses. Clin Nutr (2019) 38(5):2023–30. doi: 10.1016/j.clnu.2018.09.022
    1. Brouns F. Overweight and diabetes prevention: is a low-carbohydrate-high-fat diet recommendable? Eur J Nutr (2018) 57(4):1301–12. doi: 10.1007/s00394-018-1636-y
    1. Liang M, Pan Y, Zhong T, Zeng Y, Cheng ASK. Effects of aerobic, resistance, and combined exercise on metabolic syndrome parameters and cardiovascular risk factors: a systematic review and network meta-analysis. Rev Cardiovasc Med (2021) 22(4):1523–33. doi: 10.31083/j.rcm2204156
    1. Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest (2017) 47(8):600–11. doi: 10.1111/eci.12781
    1. Charatcharoenwitthaya P, Kuljiratitikal K, Aksornchanya O, Chaiyasoot K, Bandidniyamanon W, Charatcharoenwitthaya N. Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: A randomized clinical trial. Clin Trans Gastroenterol (2021) 12:e00316. doi: 10.14309/ctg.0000000000000316
    1. Mascaró CM, Bouzas C, Montemayor S, Casares M, Llompart I, Ugarriza L, et al. . Effect of a six-month lifestyle intervention on the physical activity and fitness status of adults with NAFLD and metabolic syndrome. Nutrients (2022) 14(9):1813. doi: 10.3390/nu14091813
    1. Jin YJ, Kim KM, Hwang S, Lee SG, Ha TY, Song GW, et al. . Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol (2012) 27(8):1341–7. doi: 10.1111/j.1440-1746.2012.07165.x
    1. Ito T, Ishigami M, Zou B, Tanaka T, Takahashi H, Kurosaki M, et al. . The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis 1995-2040. Hepatol Int (2021) 15(2):366–79. doi: 10.1007/s12072-021-10143-4
    1. Ha J, Yim SY, Karagozian R. Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Gastroenterol Hepatol (2022) 26:S1542-3565(22)01099-0. doi: 10.1016/j.cgh.2022.11.019

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere